Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.35% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTS
1851
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $11.2M | ﹤0.01% |
608,884
+67,365
| +12% | +$1.27M |
|
|
BGC
1852
DELISTED
General Cable Corporation
BGC
| $11.2M | ﹤0.01% |
751,372
+19,709
| +3% | +$276K |
|
1853
Ligand Pharmaceuticals
LGND
$5.87B
| $11.1M | ﹤0.01% |
335,431
-6,648
| -2% | -$216K |
|
|
HCT
1854
DELISTED
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
| $11.1M | ﹤0.01% |
935,499
+376,659
| +67% | +$4.27M |
|
1855
Interparfums
IPAR
$3.67B
| $11.1M | ﹤0.01% |
404,464
-39,211
| -9% | -$1.07M |
|
|
PIR
1856
DELISTED
Pier 1 Imports, Inc.
PIR
| $11M | ﹤0.01% |
35,837
+6,736
| +23% | +$1.79M |
|
1857
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $11M | ﹤0.01% |
328,540
+2,773
| +0.9% | +$90.5K |
|
|
TPH
1858
DELISTED
Tri Pointe Homes
TPH
| $11M | ﹤0.01% |
721,527
+2,594
| +0.4% | +$36.9K |
|
1859
Capitol Federal Financial
CFFN
$1.08B
| $11M | ﹤0.01% |
859,264
+1,843
| +0.2% | +$23.1K |
|
|
CUB
1860
DELISTED
Cubic Corporation
CUB
| $11M | ﹤0.01% |
208,569
-11,327
| -5% | -$557K |
|
1861
Sturm, Ruger & Co
RGR
$602M
| $11M | ﹤0.01% |
316,854
-40,683
| -11% | -$1.66M |
|
|
KERX
1862
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $11M | ﹤0.01% |
774,675
+20,435
| +3% | +$317K |
|
1863
Opko Health
OPK
$1.03B
| $10.9M | ﹤0.01% |
1,095,118
+8,272
| +0.8% | +$70.8K |
|
|
BDSI
1864
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $10.9M | ﹤0.01% |
906,580
-63,479
| -7% | -$965K |
|
|
ASPX
1865
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $10.9M | ﹤0.01% |
207,477
+77,467
| +60% | +$2.27M |
|
|
GLF
1866
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
| $10.8M | ﹤0.01% |
443,010
+93,680
| +27% | +$2.61M |
|
|
HAWK
1867
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $10.8M | ﹤0.01% |
280,213
-229,724
| -45% | -$8.17M |
|
1868
Otter Tail
OTTR
$3.9B
| $10.8M | ﹤0.01% |
348,247
-16,108
| -4% | -$476K |
|
|
BRLI
1869
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $10.7M | ﹤0.01% |
334,471
-10,706
| -3% | -$310K |
|
1870
Protolabs
PRLB
$2.2B
| $10.7M | ﹤0.01% |
159,985
-333
| -0.2% | -$21.9K |
|
|
SYNT
1871
DELISTED
Syntel Inc
SYNT
| $10.7M | ﹤0.01% |
238,552
+2,600
| +1% | +$114K |
|
|
HMHC
1872
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $10.7M | ﹤0.01% |
517,309
+23,934
| +5% | +$478K |
|
|
HDS
1873
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.7M | ﹤0.01% |
363,152
+16,109
| +5% | +$452K |
|
1874
iShares S&P Small-Cap 600 Value ETF
IJS
$8.45B
| $10.7M | ﹤0.01% |
181,442
+129,268
| +248% | +$7.29M |
|
|
KW
1875
DELISTED
Kennedy-Wilson Holdings
KW
| $10.7M | ﹤0.01% |
422,267
+43,057
| +11% | +$1.11M |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.